Читать книгу Fundamentals of Cancer Detection, Treatment, and Prevention - Surya K. De - Страница 80

1 1 Rossouw, J.E., Anderson, G.L., Prentice, R.L. et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (3): 321–333.

2 2 Anderson, G.L., Limacher, M., Assaf, A.R. et al. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 (14): 1701–1712.

3 3 LaCroix, A.Z., Chlebowski, R.T., Manson, J.E. et al. (2011). Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 305 (13): 1305–1314.

4 4 Chlebowski, R.T., Anderson, G., Pettinger, M. et al. (2008). Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Archives of Internal Medicine 168 (4): 370–377.

5 5 Chlebowski, R.T., Kuller, L.H., Prentice, R.L. et al. (2009). Breast cancer after use of estrogen plus progestin in postmenopausal women. New England Journal of Medicine 360 (6): 573–587.

6 6 Chlebowski, R.T., Schwartz, A.G., Wakelee, H. et al. (2009). Estrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post‐hoc analysis of a randomised controlled trial. Lancet 374 (9697): 1243–1251.

7 7 Crandall, C.J., Hovey, K.M., Andrews, C.A. et al. (2018). Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause 25 (1): 11–20.

8 8 Holmberg, L. and Anderson, H. (2004). HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped. Lancet 363 (9407): 453–455.

9 9 Pachman, D.R., Jones, J.M., and Loprinzi, C.L. (2010). Management of menopause‐associated vasomotor symptoms: current treatment options, challenges and future directions. International Journal of Women's Health 2: 123–135.

10 10 Franco, O.H., Chowdhury, R., Troup, J. et al. (2016). Use of plant‐based therapies and menopausal symptoms: a systematic review and meta‐analysis. JAMA 315 (23): 2554–2563.

11 11 Flegal, K.M., Kruszon‐Moran, D., Carroll, M.D. et al. (2016). Trends in obesity among adults in the United States. JAMA 315 (21): 2284–2291.

12 12 Kushi, L.H., Doyle, C., McCullough, M. et al. (2012). American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA: A Cancer Journal for Clinicians 62 (1): 30–67. https://doi.org/10.3322/caac.20140. PMID: 22237782.

13 13 Bleyer, A. (2007). Young adult oncology: the patients and their survival challenges. CA: A Cancer Journal for Clinicians 57: 242–255.

14 14 Lam, J.U., Rebolj, M., Dugué, P.A. et al. (2014). Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies. Journal of Medical Screening 21 (1): 38–50.

15 15 Winer, R.L., Hughes, J.P., Feng, Q. et al. (2006). Condom use and the risk of genital human papillomavirus infection in young women. The New England Journal of Medicine 354: 2645–2654.

16 16 Hales, C.M., Fryar, C.D., Carroll, M.D. et al. (2018). Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016. JAMA 319 (16): 1723–1725.

17 17 Thomson, C.A., McCullough, M.L., Wertheim, B.C. et al. (2014). Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women's health initiative. Cancer Prevention Research (Philadelphia, Pa.) 1: 42–53.

18 18 Rock, C.L., Thomson, C., Gansler, T. et al. (2020). American Cancer Society guideline for diet and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians 70 (4): 245–271. https://doi.org/10.3322/caac.21591. Epub 9 June 2020. PMID: 32515498.

19 19 Bagnardi, V., Rota, M., Botteri, E. et al. (2013). Light alcohol drinking and cancer: a meta‐analysis. Annals of Oncology 24 (2): 301–308.

20 20 Bagnardi, V., Rota, M., Botteri, E. et al. (2015). Alcohol consumption and site‐specific cancer risk: a comprehensive dose‐response meta‐analysis. British Journal of Cancer 112 (3): 580–593.

21 21 Cao, Y., Willett, W.C., Rimm, E.B. et al. (2015). Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies. BMJ 351: h4238.

22 22 Chen, W.Y., Rosner, B., Hankinson, S.E. et al. (2011). Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 306 (17): 1884–1890.

23 23 White, A.J., DeRoo, L.A., Weinberg, C.R., and Sandler, D.P. (2017). Lifetime alcohol intake, binge drinking behaviors, and breast cancer risk. American Journal of Epidemiology 186 (5): 541–549.

24 24 Fan, X., Peters, B.A., Jacobs, E.J. et al. (2018). Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. Microbiome 6 (1): 59.

25 25 Rehm, J., Patra, J., and Popova, S. (2007). Alcohol drinking cessation and its effect on esophageal and head and neck cancers: a pooled analysis. International Journal of Cancer 121 (5): 1132–1137.

26 26 Ahmad Kiadaliri, A., Jarl, J., Gavriilidis, G., and Gerdtham, U.G. (2013). Alcohol drinking cessation and the risk of laryngeal and pharyngeal cancers: a systematic review and meta‐analysis. PLoS One 8 (3): e58158.

27 27 Chao, C., Haque, R., Caan, B.J. et al. (2010). Red wine consumption not associated with reduced risk of colorectal cancer. Nutrition and Cancer 62 (6): 849–855.

28 28 Wu, C., Wang, Z., Song, X. et al. (2014). Joint analysis of three genome‐wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nature Genetics 46 (9): 1001–1006.

29 29 Vartolomei, M.D., Kimura, S., Ferro, M. et al. (2018). The impact of moderate wine consumption on the risk of developing prostate cancer. Clinical Epidemiology 10: 431–444.

30 30 Yokoyama, A. and Omori, T. (2005). Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers exit disclaimer. Alcohol 35 (3): 175–185.

31 31 Kanda, J., Matsuo, K., Suzuki, T. et al. (2009). Impact of alcohol consumption with polymorphisms in alcohol‐metabolizing enzymes on pancreatic cancer risk in Japanese. Cancer Science 100 (2): 296–302.

32 32 Nelson, D.E., Jarman, D.W., Rehm, J. et al. (2013). Alcohol‐attributable cancer deaths and years of potential life lost in the United States. American Journal of Public Health 103 (4): 641–648.

33 33 LoConte, N.K., Brewster, A.M., Kaur, J.S. et al. (2018). Alcohol and cancer: a statement of the American Society of clinical oncology. Journal of Clinical Oncology 36 (1): 83–93.

34 34 Hashibe, M., Brennan, P., Chuang, S.C. et al. (2009). Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiology, Biomarkers & Prevention 18 (2): 541–550.

35 35 Grewal, P. and Viswanathen, V.A. (2012). Liver cancer and alcohol. Clinics in Liver Disease 16 (4): 839–850.

36 36 Petrick, J.L., Campbell, P.T., Koshiol, J. et al. (2018). Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the liver cancer pooling project. British Journal of Cancer 118 (7): 1005–1012.

37 37 Fedirko, V., Tramacere, I., Bagnardi, V. et al. (2011). Alcohol drinking and colorectal cancer risk: an overall and dose‐response meta‐analysis of published studies. Annals of Oncology 22 (9): 1958–1972.

38 38 Mahabir, S., Leitzmann, M.F., Virtanen, M.J. et al. (2005). Prospective study of alcohol drinking and renal cell cancer risk in a cohort of finnish male smokers. Cancer Epidemiology, Biomarkers & Prevention 14 (1): 170–175.

39 39 Rashidkhani, B., Akesson, A., Lindblad, P., and Wolk, A. (2005). Alcohol consumption and risk of renal cell carcinoma: a prospective study of Swedish women. International Journal of Cancer 117 (5): 848–853.

40 40 Lee, J.E., Hunter, D.J., Spiegelman, D. et al. (2007). Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. Journal of the National Cancer Institute 99 (10): 801–810.

41 41 Psaltopoulou, T., Sergentanis, T.N., Ntanasis‐Stathopoulos, I. et al. (2018). Alcohol consumption and risk of hematological malignancies: a meta‐analysis of prospective studies. International Journal of Cancer 143 (3): 486–495.

42 42 Stornetta, A., Guidolin, V., and Balbo, S. (2018). Alcohol‐derived acetaldehyde exposure in the oral cavity. Cancers 10 (1): pii: E20.

43 43 Park, S.M., Li, T., Wu, S. et al. (2017). Risk of second primary cancer associated with pre‐diagnostic smoking, alcohol, and obesity in women with keratinocyte carcinoma. Cancer Epidemiology 47: 106–113.

44 44 Turati, F., Garavello, W., Tramacere, I. et al. (2013). A meta‐analysis of alcohol drinking and oral and pharyngeal cancers: results from subgroup analyses. Alcohol and Alcoholism 48 (1): 107–118.

45 45 Alexandrov, L.B., Ju, Y.S., Haase, K. et al. (2016). Mutational signatures associated with tobacco smoking in human cancer. Science 354 (6312): 618–622.

46 46 Druesne‐Pecollo, N., Keita, Y., Touvier, M. et al. (2014). Alcohol drinking and second primary cancer risk in patients with upper aerodigestive tract cancers: a systematic review and meta‐analysis of observational studies. Cancer Epidemiology, Biomarkers & Prevention 23 (2): 324–331.

47 47 Simapivapan, P., Boltong, A., and Hodge, A. (2016). To what extent is alcohol consumption associated with breast cancer recurrence and second primary breast cancer?: a systematic review. Cancer Treatment Reviews 50: 155–167.

48 48 Park, S.M., Li, T., Wu, S. et al. (2017). Risk of second primary cancer associated with pre‐diagnostic smoking, alcohol, and obesity in women with keratinocyte carcinoma. Cancer Epidemiology 47: 106–113.

49 49 Knight, J.A., Fan, J., Malone, K.E. et al. (2017). Alcohol consumption and cigarette smoking in combination: a predictor of contralateral breast cancer risk in the WECARE study. International Journal of Cancer 141 (5): 916–924.

50 50 Yokoyama, A. and Omori, T. (2005). Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers exit disclaimer. Alcohol 35 (3): 175–185.

51 51 Baker, F., Ainsworth, S.R., Dye, J.T. et al. (2000). Health risks associated with cigar smoking. Journal of the American Medical Association 284 (6): 735–740.

52 52 Kozlowski, L.T., Dollar, K.M., and Giovino, G.A. (2008). Cigar/cigarillo surveillance: limitations of the U.S. Department of agriculture system. American Journal of Preventive Medicine 34 (5): 424–426.

53 53 Tynan, M.A., Holmes, C.B., Promoff, G. et al. (2016). State and local comprehensive smoke‐free laws for worksites, restaurants, and bars – United States, 2015. MMWR. Morbidity and Mortality Weekly Report 65 (24): 623–626.

54 54 Tsai, J., Homa, D.M., Gentzke, A.S. et al. (2018). Exposure to secondhand smoke among nonsmokers United States, 1988–2014. MMWR. Morbidity and Mortality Weekly Report 67: 1342–1346.

55 55 Jha, P., Ramasundarahettige, C., Landsman, V. et al. (2013). 21st‐century hazards of smoking and benefits of cessation in the United States. New England Journal of Medicine 368 (4): 341–350.

56 56 Nash, S.H., Liao, L.M., Harris, T.B., and Freedman, N.D. (2017). Cigarette smoking and mortality in adults aged 70 years and older: results from the NIH‐AARP cohort. American Journal of Preventive Medicine 52 (3): 276–283.

57 57 Hecht, S.S. (2003). Tobacco carcinogens, their biomarkers and tobacco‐induced cancer. Nature Reviews Cancer 3 (10): 733–744.

58 58 Austoni, E., Mirone, V., Parazzini, F. et al. (2005). Smoking as a risk factor for erectile dysfunction: data from the andrology prevention weeks 2001–2002. A study of the Italian Society of Andrology (S.I.A.). European Urology 48 (5): 810–818.

59 59 Hatsukami, D.K., Stead, L.F., and Gupta, P.C. (2008). Tobacco addiction. Lancet 371 (9629): 2027–2038.

60 60 Piano, M.R., Benowitz, N.L., Fitzgerald, G.A. et al. (2010). Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation 122 (15): 1520–1544.

61 61 Villanti, A.C., Richardson, A., Vallone, D.M., and Rath, J.M. (2013). Flavored tobacco product use among U.S. young adults. American Journal of Preventive Medicine 44 (4): 388–391.

62 62 Walter, V., Jansen, L., Hoffmeister, M., and Brenner, H. (2014). Smoking and survival of colorectal cancer patients: systematic review and meta‐analysis. Annals of Oncology 25 (8): 1517–1525.

63 63 Warren, G.W., Kasza, K.A., Reid, M.E. et al. (2013). Smoking at diagnosis and survival in cancer patients. International Journal of Cancer 132 (2): 401–410.

64 64 Parsons, A., Daley, A., Begh, R., and Aveyard, P. (2010). Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta‐analysis. British Medical Journal 340: b5569.

65 65 Travis, L.B., Rabkin, C.S., Brown, L.M. et al. (2006). Cancer survivorship – genetic susceptibility and second primary cancers: research strategies and recommendations. Journal of the National Cancer Institute 98 (1): 15–25.

66 66 Peto, R., Darby, S., Deo, H. et al. (2000). Smoking, smoking cessation, and lung cancer in the U.K. since 1950: combination of national statistics with two case‐control studies. British Medical Journal 321 (7257): 323–329.

67 67 Inoue‐Choi, M., Hartge, P., Liao, L.M. et al. (2018). Association between long‐term low‐intensity cigarette smoking and incidence of smoking‐related cancer in the National Institutes of Health‐AARP cohort. International Journal of Cancer 142 (2): 271–280.

68 68 Prignot, J.J., Sasco, A.J., Poulet, E. et al. (2008). Alternative forms of tobacco use. The International Journal of Tuberculosis and Lung Disease 12 (7): 718–727.

69 69 Smith‐Simone, S., Maziak, W., Ward, K.D., and Eissenberg, T. (2008). Waterpipe tobacco smoking: knowledge, attitudes, beliefs, and behavior in two U.S. samples. Nicotine & Tobacco Research 10 (2): 393–398.

70 70 Corey, C.G., Ambrose, B.K., Apelberg, B.J., and King, B.A. (2014). Flavored tobacco product use among middle and high school students‐‐United States. MMWR Morbidity and Mortality Weekly Report 2015 64 (38): 1066–1070.

71 71 Henley, S.J., Thun, M.J., Chao, A., and Calle, E.E. (2004). Association between exclusive pipe smoking and mortality from cancer and other diseases. Journal of the National Cancer Institute 96 (11): 853–861.

72 72 Wyss, A., Hashibe, M., Chuang, S.C. et al. (2013). Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. American Journal of Epidemiology 178 (5): 679–690.

73 73 Fontham, E.T.H., Wolf, A.M.D., Church, T.R. et al. (2020). Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA: A Cancer Journal for Clinicians 70 (5): 321–346.

74 74 Leyden, W.A., Manos, M.M., Geiger, A.M. et al. (2005). Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. Journal of the National Cancer Institute 97 (9): 675–683.

75 75 Saslow, D., Andrews, K.S., Manassaram‐Baptiste, D. et al. (2020). Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation. CA: A Cancer Journal for Clinicians 70 (4): 274–280. https://doi.org/10.3322/caac.21616. Epub 8 July 2020. PMID: 32639044.

76 76 Berger, A.H. and Pandolfi, P.P. (2011). Cancer susceptibility syndromes. In: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology, 8e (ed. V.T. DeVita, T.S. Lawrence and S.A. Rosenberg), 161–172. Philadelphia, PA: Lippincott Williams & Wilkins, a Part of Wolters Kluwer Health Adis (ESP).

77 77 Boniol, M., Autier, P., Boyle, P., and Gandini, S. (2012). Cutaneous melanoma attributable to sunbed use: systematic review and meta‐analysis. BMJ 345: e4757.

78 78 Centers for Disease Control and Prevention. Skin Cancer Prevention Progress Report 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017.

79 79 Wehner, M.R., Shive, M.L., Chren, M.M. et al. (2012). Indoor tanning and non‐melanoma skin cancer: systematic review and meta‐analysis. BMJ 345: e590.

80 80 Hornung, R.W. (2001). Health effects in underground uranium wminers. Occupational Medicine 16: 331–344.

81 81 Schubauer‐Berigan, M.K., Daniels, R.D., and Pinkerton, L.E. (2009). Radon exposure and mortality among white and American Indian uranium miners: an update of the Colorado Plateau cohort. American Journal of Epidemiology 169: 718–730.

82 82 Falzone, L., Marconi, A., Loreto, C. et al. (2016). Occupational exposure to carcinogens: benzene, pesticides and fibers. Molecular Medicine Reports 14 (5): 4467–4474.

83 83 National Toxicology Program (2016). Coal Tars and Coal‐Tar Pitches, Report on Carcinogens, 14e. Triangle Park, NC: National Institute of Environmental Health and Safety.

84 84 Paghdal, K.V. and Schwartz, R.A. (2009). Topical tar: back to the future. Journal of the American Academy of Dermatology 61 (2): 294–302.

85 85 Attfield, M.D., Schleiff, P.L., Lubin, J.H. et al. (2012). The diesel exhaust in miners study: a cohort mortality study with emphasis on lung cancer. Journal of the National Cancer Institute 104: 869–883.

86 86 Boffetta, P., Stellman, S.D., and Garfinkel, L. (1988). Diesel exhaust exposure and mortality among males in the American Cancer Society prospective study. American Journal of Industrial Medicine 14: 403–415.

87 87 Frumkin, H. and Thun, M.J. (2001). Diesel exhaust. CA: A Cancer Journal for Clinicians 51: 193–198.

88 88 Garshick, E., Schenker, M.B., Muñoz, A. et al. (1987). A case‐control study of lung cancer and diesel exhaust exposure in railroad workers. The American Review of Respiratory Disease 135: 1242–1248.

89 89 Heinrich, U., Muhle, H., Takenaka, S. et al. (1986). Chronic effects on the respiratory tract of hamsters, mice, and rats after long‐term inhalation of high concentrations of filtered and unfiltered diesel engine emissions. Journal of Applied Toxicology 6: 383–395.

90 90 Madden, M.C. (2008). Complex issues with examining diesel exhaust toxicity: is the task getting easier or harder? Experimental and Toxicologic Pathology 60: 135–140.

91 91 Mauderly, J.L., Jones, R.K., Griffith, W.C. et al. (1987). Diesel exhaust is a pulmonary carcinogen in rats exposed chronically by inhalation. Fundamental and Applied Toxicology 9: 208–221.

92 92 Silverman, D.T., Samanic, C.M., Lubin, J.H. et al. (2012). The diesel exhaust in miners study: a nested case‐control study of lung cancer and diesel exhaust. Journal of the National Cancer Institute 104: 855–868.

93 93 Steenland, K., Silverman, D.T., and Hornung, R.W. (1990). Case‐control study of lung cancer and truck driving in the Teamsters Union. American Journal of Public Health 80: 670–674.

94 94 Steenland, K., Silverman, D.T., and Zaebst, D. (1992). Exposures to diesel exhaust in the trucking industry and possible relationships with lung cancer. American Journal of Industrial Medicine 21: 887–890.

95 95 Vermeulen, R., Silverman, D.T., Garshick, E. et al. (2014). Exposure‐response estimates for diesel engine exhaust and lung cancer mortality based on data from three occupational cohorts. Environmental Health Perspectives 122: 172–177.

96 96 Vogel, L. (2017). Fracking tied to cancer‐causing chemicals. CMAJ 189 (2): E94–E95.

97 97 Jaklitsch, M.T., Jacobson, F.L., Austin, J.H. et al. (2012). The American Association for thoracic surgery guidelines for lung cancer screening using low‐dose computed tomography scans for lung cancer survivors and other high‐risk groups. The Journal of Thoracic and Cardiovascular Surgery 144: 33–38.

98 98 Markowitz, S.B., Levin, S.M., Miller, A., and Morabia, A. (2013). Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. American Journal of Respiratory and Critical Care Medicine 188: 90–96.

99 99 Hauptmann, M., Stewart, P.A., Lubin, J.H. et al. (2009). Mortality from lymphohematopoietic malignancies and brain cancer among embalmers exposed to formaldehyde. Journal of the National Cancer Institute 101 (24): 1696–1708.

100 100 Hauptmann, M., Lubin, J.H., Stewart, P.A. et al. (2003). Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. Journal of the National Cancer Institute 95 (21): 1615–1623.

101 101 Beane Freeman, L., Blair, A., Lubin, J.H. et al. (2009). Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: The National Cancer Institute Cohort. Journal of the National Cancer Institute 101 (10): 751–761.

102 102 Pinkerton, L.E., Hein, M.J., and Stayner, L.T. (2004). Mortality among a cohort of garment workers exposed to formaldehyde: An update. Occupational and Environmental Medicine 61: 193–200.

103 103 Coggon, D., Harris, E.C., Poole, J., and Palmer, K.T. (2003). Extended follow‐up of a cohort of British chemical workers exposed to formaldehyde. Journal of the National Cancer Institute 95 (21): 1608–1615.

104 104 Hauptmann, M., Lubin, J.H., Stewart, P.A. et al. (2004). Mortality from solid cancers among workers in formaldehyde industries. American Journal of Epidemiology 159 (12): 1117–1130.

105 105 Lelieveld, J., Evans, J., Fnais, M. et al. (2015). The contribution of outdoor air pollution sources to premature mortality on a global scale. Nature 525: 367–371.

106 106 Turner, M.C., Andersen, Z.J., Baccarelli, A. et al. (2020). Outdoor air pollution and cancer: an overview of the current evidence and public health recommendations. CA: A Cancer Journal for Clinicians 70: 460–479.

107 107 Stadler, R.H., Blank, I., Varga, N. et al. (2002). Acrylamide from Maillard reaction products. Nature 419 (6906): 449–450.

108 108 Mottram, D.S., Wedzicha, B.L., and Dodson, A.T. (2002). Acrylamide is formed in the Maillard reaction. Nature 419 (6906): 448–449.

109 109 Kita, A., Brathen, E., Knutsen, S.H., and Wicklund, T. (2004). Effective ways of decreasing acrylamide content in potato crisps during processing. Journal of Agricultural and Food Chemistry 52 (23): 7011–7016.

110 110 Virk‐Baker, M.K., Nagy, T.R., Barnes, S., and Groopman, J. (2014). Dietary acrylamide and human cancer: a systematic review of literature. Nutrition and Cancer 66 (5): 774–790.

111 111 Friedman, M. (2003). Chemistry, biochemistry, and safety of acrylamide. A review. Journal of Agricultural and Food Chemistry 51 (16): 4504–4526.

112 112 Dearfield, K.L., Abernathy, C.O., Ottley, M.S. et al. (1988). Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutation Research 195 (1): 45–77.

113 113 Lipworth, L., Sonderman, J.S., Tarone, R.E., and McLaughlin, J.K. (2012). Review of epidemiologic studies of dietary acrylamide intake and the risk of cancer. European Journal of Cancer Prevention 21 (4): 375–386.

114 114 Fennell, T.R. and Friedman, M.A. (2005). Comparison of acrylamide metabolism in humans and rodents. Advances in Experimental Medicine and Biology 561: 109–116.

115 115 Gargas, M.L., Kirman, C.R., Sweeney, L.M., and Tardiff, R.G. (2009). Acrylamide: consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion. Food and Chemical Toxicology 47 (4): 760–768.

116 116 Mulloy, K.B. (1996). Two case reports of neurological disease in coal mine preparation plant workers. American Journal of Industrial Medicine 30 (1): 56–61.

117 117 Pelucchi, C., La Vecchia, C., Bosetti, C. et al. (2011). Exposure to acrylamide and human cancer‐‐a review and meta‐analysis of epidemiologic studies. Annals of Oncology 22 (7): 1487–1499.

118 118 Cohen, S.M. and Arnold, L.L. (2011). Chemical carcinogenesis. Toxicological Sciences 120 (suppl_1): S76–S92.

119 119 Beyersmann, D. and Hartwig, A. (2008). Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Archives of Toxicology 82 (8): 493–512.

120 120 Tricker, A.R. and Preussmann, R. (1991). Carcinogenic N‐nitrosamines in the diet: occurrence, formation, mechanisms and carcinogenic potential. Mutation Research/Genetic Toxicology 259 (3–4): 277–289.

121 121 Bolton, J.L. and Thatcher, G.R. (2008). Potential mechanisms of estrogen quinone carcinogenesis. Chemical Research in Toxicology 21 (1): 93–101.

122 122 Scanlan, R.A. (1983). Formation and occurrence of nitrosamines in food. Cancer Research 43 (5 Suppl): 2435–2440.

123 123 Virk‐Baker, M.K., Nagy, T.R., Barnes, S., and Groopman, J. (2014). Dietary acrylamide and human cancer: a systematic review of literature. Nutrition and Cancer 66 (5): 774–790.

124 124 Mottram, D.S., Wedzicha, B.L., and Dodson, A.T. (2002). Acrylamide is formed in the Maillard reaction. Nature 419 (6906): 448–449.

125 125 Tamanna, N. and Mahmood, N. (2015). Food processing and maillard reaction products: effect on human health and nutrition. International Journal of Food Science 2015: 526762.

126 126 Stadler, R.H., Robert, F., Riediker, S. et al. (2004). In‐depth mechanistic study on the formation of acrylamide and other vinylogous compounds by the maillard reaction. Journal of Agricultural and Food Chemistry 52 (17): 5550–5558.

127 127 American Cancer Society (2018). ACS guidelines for the early detection of cancer. https://www.cancer.org/healthy/find-cancer-early/cancer-screening-guidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer.html (accessed 28 November 2018).

128 128 Centers for Disease Control and Prevention (CDC) (2018). Tobacco and cancer. https://www.cdc.gov/cancer/tobacco/index.htm (accessed 1 February 2018).

129 129 National Institutes of Health (NIH)/National Cancer Institute (2018). Risk factors for cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk (accessed 31 January 2018).

130 130 Anand, P., Ajaikumar, B., Sundaram, C. et al. (2008). Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical Research 25: 2097.

131 131 Skin Cancer Foundation (2018). Skin cancer facts and statistics. https://www.skincancer.org/skin-cancer-information/skin-cancer-facts#general (accessed 31 January 2018).

132 132 World Health Organization (2018). Cancer fact sheet. http://www.who.int/news-room/fact-sheets/detail/cancer (accessed 1 February 2018).

133 133 World Health Organization Cancer fact sheet. http://www.who.int/news-room/fact-sheets/detail/cancer (accessed 1 February 2018).

134 134 World Health Organization (WHO) (2019). Ultraviolet radiation (UV): the known health effects of UV. https://www.who.int/uv/faq/uvhealtfac/en/index1.html (accessed 7 June 2019).

135 135 Environmental Protection Agency (2013). Consumer's Guide to Radon Reduction. www.epa.gov/radon/pubs/consguid.html (accessed 25 May 2015).

136 136 Daniel, G., Vanderhoorn, S., Lopez, A.D. et al. (2005). Causes of cancer in the world: comparative risk assessment of nine behavioral and environmental risk factors. The Lancet 366: 1784.